Feature

Psychiatric subspecialty is changing its name


 

Constantine G. Lyketsos, MD, remembers when the Academy of Psychosomatic Medicine held annual meetings that attracted 200. Now, the subspecialty organization’s meeting attracts about 1,000 people, and is getting a new name to reflect that growth.

“The field has grown substantially, and I think it will grow further with this name change,” said Dr. Lyketsos, who along with James L. Levenson, MD, spearheaded the effort to have the subspecialty recognized almost 20 years ago. “The field is the same. [But the] name change is going to change the way we are perceived by our primary customers – the patients. It will probably be a positive development for our trainees.”


The organization will be rebranded as the Academy of Consultation-Liaison Psychiatry. The name change, aimed in part at shedding the ambiguity around the word “psychosomatic” and better capturing the mission of consultation-liaison psychiatry, will be reflected across the group’s platforms. The tagline on the group’s journal, Psychosomatics, will become “The Journal of Consultation-Liaison Psychiatry,” and the theme of the group’s November 2018 annual meeting in Orlando will focus on the rebranding. The academy also has changed its web address to clpsychiatry.org.

“I’m a consultation-liaison psychiatrist, and I think that clears the air from the very beginning,” said Dr. Lyketsos, professor and chair of psychiatry at Johns Hopkins Bayview in Baltimore.

Pages

Recommended Reading

High-intensity treadmill workouts preserved motor function in early-stage Parkinson’s
MDedge Internal Medicine
Gene silencer reduces mutant huntingtin protein in early-stage Huntington’s patients
MDedge Internal Medicine
Corynebacterium in the gut can trigger Parkinson’s disease
MDedge Internal Medicine
Low caffeine in blood could be marker of early Parkinson’s
MDedge Internal Medicine
FDA cites manufacturer of autologous stem cells for regulatory, manufacturing missteps
MDedge Internal Medicine
Mutations on LRRK2 gene modify risks for both Crohn’s and Parkinson’s
MDedge Internal Medicine
Mogamulizumab active in HTLV-1–associated myelopathy
MDedge Internal Medicine
Office-based screen predicts dementia in Parkinson’s disease
MDedge Internal Medicine
Distinguish neurogenic from nonneurogenic orthostatic hypotension
MDedge Internal Medicine
MDedge Daily News: Could gut bacteria trigger lupus?
MDedge Internal Medicine